Security
NORTHWEST BIOTHERAPEUTICS INC Common Stock · NWBO
NWBOOTCCommon stockHistorical · closed Dec 16, 2016CIK 1072379Updated Nov 2, 2026
Current security for this SEC filerNWBO · OTC
NWBO price & chart
Historical security
This listing closed Dec 16, 2016. Live provider charts are shown only for current listings.
Current security: NWBO
In the news
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities ↗
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed USA - English USA - English News provided by Northwest Biotherapeutics, Inc. Oct 24, 2025, 12:30 ET Share this article Share to X Share this article Share to X BETHESDA, Md. , Oct. 24, 2025 /PRNewswire/ -- ↗
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed USA - English USA - English News provided by Northwest Biotherapeutics, Inc. Oct 24, 2025, 12:03 ET Share this article Share to X Share this article Share to X BETHESDA, Md. , Oct. 24, 2025 /PRNewswire/ -- ↗
Recent filings
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03
10-Q filing
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03
424B5 filing
Regulation FD Disclosure
Items 7.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 30,609,000Source | 29,321,000Source | 75,941,000Source | 29,547,000Source | 28,225,000Source | 80,051,000Source | 27,505,000Source | 28,567,000Source | 81,290,000Source | 26,728,000Source | 27,865,000Source | 31,323,000Source |
| Property, Plant and Equipment, NetUSD | 16,870,000Source | 17,322,000Source | 16,476,000Source | 16,685,000Source | 16,962,000Source | 16,771,000Source | 16,288,000Source | 17,268,000Source | 17,406,000Source | 16,196,000Source | 17,278,000Source | 13,418,000Source |
| GoodwillUSD | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | 51,932,000Source | — | — | 52,048,000Source | — | — | 53,188,000Source | — | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 4,560,000Source | 2,939,000Source | 595,000Source | 4,316,000Source | 2,881,000Source | 1,786,000Source | 2,779,000Source | 2,478,000Source | 3,040,000Source | 2,175,000Source | 2,126,000Source | 6,965,000Source |
| Assets, CurrentUSD | 7,198,000Source | 5,192,000Source | 2,574,000Source | 6,155,000Source | 4,976,000Source | 6,202,000Source | 4,686,000Source | 4,948,000Source | 5,517,000Source | 4,062,000Source | 4,125,000Source | 9,425,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,327,000Source | 2,253,000Source | 1,979,000Source | 1,839,000Source | 2,095,000Source | 4,416,000Source | 1,907,000Source | 2,470,000Source | 2,166,000Source | 1,887,000Source | 1,999,000Source | 2,460,000Source |
| Operating Lease, Right-of-Use AssetUSD | 4,265,000Source | 4,515,000Source | 3,979,000Source | 4,419,000Source | 3,997,000Source | 4,050,000Source | 4,246,000Source | 4,070,000Source | 4,197,000Source | 4,187,000Source | 4,183,000Source | 4,189,000Source |
| Other Assets, NoncurrentUSD | 358,000Source | 374,000Source | 354,000Source | 370,000Source | 372,000Source | 354,000Source | 367,000Source | 363,000Source | 356,000Source | 365,000Source | 361,000Source | 345,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 125,857,000Source | 93,561,000Source | 110,717,000Source | 116,183,000Source | 85,969,000Source | 118,111,000Source | 112,343,000Source | 82,039,000Source | 128,860,000Source | 105,708,000Source | 74,920,000Source | 136,366,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 1,518,000Source | 1,286,000Source | 1,681,000Source | 1,459,000Source | 1,229,000Source | 1,619,000Source | 1,391,000Source | 1,195,000Source | 1,567,000Source | 1,328,000Source | 1,175,000Source | 1,068,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,505,049,000Source | -1,415,276,000Source | -1,515,951,000Source | -1,478,220,000Source | -1,395,902,000Source | -1,506,730,000Source | -1,462,842,000Source | -1,378,033,000Source | -1,503,661,000Source | -1,443,499,000Source | -1,359,721,000Source | -1,297,122,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,217,000Source | -29,000Source | -246,000Source | -1,849,000Source | 2,224,000Source | -429,000Source | 1,399,000Source | 2,150,000Source | -925,000Source | 3,043,000Source | 1,536,000Source | 3,145,000Source |
| Stockholders' Equity Attributable to ParentUSD | -108,648,000Source | -80,117,000Source | -45,174,000Source | -100,389,000Source | -76,497,000Source | -50,544,000Source | -99,479,000Source | -73,282,000Source | -60,280,000Source | -94,487,000Source | -65,773,000Source | -128,103,000Source |
| Additional Paid in Capital, Common StockUSD | 1,396,179,000Source | 1,333,981,000Source | 1,469,433,000Source | 1,378,300,000Source | 1,316,031,000Source | 1,455,087,000Source | 1,360,652,000Source | 1,301,485,000Source | 1,442,830,000Source | 1,344,720,000Source | 1,291,316,000Source | 1,164,885,000Source |
| Liabilities and EquityUSD | 30,609,000Source | 29,321,000Source | 75,941,000Source | 29,547,000Source | 28,225,000Source | 80,051,000Source | 27,505,000Source | 28,567,000Source | 81,290,000Source | 26,728,000Source | 27,865,000Source | 31,323,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 87,905,000Source | 59,564,000Source | 73,352,000Source | 83,921,000Source | 56,174,000Source | 82,973,000Source | 83,059,000Source | 62,440,000Source | 91,700,000Source | 68,274,000Source | 45,204,000Source | 126,005,000Source |
| Operating Lease, Liability, CurrentUSD | 399,000Source | 256,000Source | 212,000Source | 448,000Source | 175,000Source | 274,000Source | 390,000Source | 245,000Source | 374,000Source | 326,000Source | 314,000Source | 354,000Source |
| Operating Lease, Liability, NoncurrentUSD | 4,447,000Source | 4,828,000Source | 4,256,000Source | 4,624,000Source | 4,361,000Source | 4,291,000Source | 4,471,000Source | 4,384,000Source | 4,411,000Source | 4,438,000Source | 4,454,000Source | 4,370,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | 12,962,000Source | — | — | 12,936,000Source | — | — | 13,171,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 13,171,000Source | — | — | — |
| Long-term DebtUSD | 72,201,000Source | 53,251,000Source | 51,973,000Source | 64,736,000Source | 51,038,000Source | 59,429,000Source | 64,144,000Source | 44,448,000Source | 60,042,000Source | 62,676,000Source | 40,792,000Source | 21,529,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | 3,100,000Source | -19,300,000Source | -60,200,000Source | -83,800,000Source | -62,800,000Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 3,600,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -12,509,000Source | -9,418,000Source | -44,763,000Source | -57,017,000Source | -53,637,000Source | -52,775,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -129,000Source | -93,000Source | -1,815,000Source | -1,014,000Source | -3,437,000Source | -2,902,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 129,000Source | 93,000Source | 1,504,000Source | — | — | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 9,209,000Source | 11,733,000Source | 49,327,000Source | 56,785,000Source | 52,758,000Source | 41,968,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,254,000Source | 604,000Source | 865,000Source | 49,000Source | -4,839,000Source | -8,204,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 4,560,000Source | 2,939,000Source | 595,000Source | 4,316,000Source | 1,786,000Source | 2,779,000Source | 3,040,000Source | 2,175,000Source | 2,126,000Source | 6,965,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 273,000Source | 689,000Source | 181,000Source | 364,000Source | 288,000Source | 385,000Source | 1,207,000Source | 3,456,000Source | 4,408,000Source | 12,298,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | 499,000Source | 676,000Source | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | 400,000Source | 500,000Source | — | 500,000Source | — | 300,000Source | — | — | 2,400,000Source | — |
| DepreciationUSD | — | — | — | — | 500,000Source | 500,000Source | 600,000Source | 400,000Source | 1,900,000Source | 1,700,000Source | 1,500,000Source | 1,300,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | -3,332,000Source | -1,590,000Source | — | 724,000Source | 9,416,000Source | 1,280,000Source | -151,000Source | 364,000Source | 3,644,000Source | -25,821,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -808,000Source | 2,760,000Source | -123,000Source | 3,640,000Source | -1,344,000Source | 1,898,000Source | 4,915,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | 2,760,000Source | — | 3,640,000Source | — | 1,898,000Source | — | -1,548,000Source | 2,008,000Source | -3,304,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -4,004,000Source | -6,820,000Source | -2,180,000Source | -4,516,000Source | -4,756,000Source | -7,282,000Source | -17,397,000Source | -14,393,000Source | -5,403,000Source | -2,691,000Source |
| General and Administrative ExpenseUSD | — | — | 7,070,000Source | 7,028,000Source | 6,707,000Source | 7,480,000Source | 6,536,000Source | 9,335,000Source | 32,507,000Source | 33,002,000Source | 29,710,000Source | 33,353,000Source |
| GoodwillUSD | — | — | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source | 626,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -537,000Source | 0Source | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | — | — | 2,621,000Source | 2,080,000Source | 1,809,000Source | 1,826,000Source | 2,346,000Source | 1,602,000Source | 8,695,000Source | 7,767,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -26,829,000Source | -19,374,000Source | -9,221,000Source | -15,378,000Source | -3,069,000Source | -19,343,000Source | -60,162,000Source | -83,778,000Source | -62,599,000Source | -105,032,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -27,182,000Source | -19,506,000Source | -9,553,000Source | -15,938,000Source | -3,400,000Source | -19,608,000Source | -61,477,000Source | -85,192,000Source | -64,373,000Source | -105,032,000Source |
| Operating Costs and ExpensesUSD | — | — | 14,520,000Source | 15,158,000Source | 12,412,000Source | 14,910,000Source | 11,394,000Source | 17,686,000Source | 61,292,000Source | 67,890,000Source | 57,440,000Source | 68,864,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -12,509,000Source | -4,573,000Source | 2,384,000Source | -599,000Source | 7,831,000Source | -2,032,000Source | -785,000Source | -17,270,000Source | -7,091,000Source | -37,851,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 2,900,000Source | 5,123,000Source | 19,319,000Source | 14,217,000Source | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | 1,932,000Source | 1,683,000Source |
| Amortization of Intangible Assets | — | — | — | — | —Source | — | —Source | — | — | — | — | — |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Induced Conversion of Convertible Debt Expense | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 200,000Source | 357,000Source | 807,000Source | 131,000Source | 494,000Source | 375,000Source | 1,378,000Source | 1,382,000Source | 1,932,000Source | 1,683,000Source |
| Operating Income (Loss)USD | — | — | -14,320,000Source | -14,801,000Source | -11,605,000Source | -14,779,000Source | -10,900,000Source | -17,311,000Source | -59,914,000Source | -66,508,000Source | -55,508,000Source | -67,181,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -12,509,000Source | -4,573,000Source | 2,384,000Source | -599,000Source | 7,831,000Source | -2,032,000Source | -785,000Source | -17,270,000Source | -7,091,000Source | -37,851,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -60,699,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -537,000Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -26,829,000Source | -19,374,000Source | -9,221,000Source | -15,378,000Source | -3,069,000Source | -19,343,000Source | -60,162,000Source | -83,778,000Source | -62,599,000Source | -105,032,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.02Source | -0.02Source | -0.01Source | -0.01Source | 0Source | -0.01Source | -0.04Source | -0.07Source | -0.06Source | -0.1Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.02Source | -0.02Source | -0.01Source | -0.01Source | 0Source | -0.01Source | -0.04Source | -0.07Source | -0.06Source | -0.1Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,492,079Source | 1,258,532Source | 1,642,439,000Source | 1,438,198,000Source | 1,584,843,000Source | 1,359,496,000Source | 1,456,663,000Source | 1,242,237Source | 1,119,191Source | 1,015,852Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,492,079Source | 1,258,532Source | 1,642,439,000Source | 1,438,198,000Source | 1,584,843,000Source | 1,359,496,000Source | 1,456,663,000Source | 1,242,237Source | 1,119,191Source | 1,015,852Source |
| Interest Expense (non-operating)USD | — | — | 2,621,000Source | 2,080,000Source | 1,809,000Source | 1,826,000Source | 2,346,000Source | 1,602,000Source | 8,695,000Source | 7,767,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 771,000Source | 434,000Source | 2,064,000Source | 1,744,000Source | 1,525,000Source | 1,252,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -808,000Source | 2,760,000Source | -123,000Source | 3,640,000Source | -1,344,000Source | 1,898,000Source | 4,915,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | 2,760,000Source | — | 3,640,000Source | — | 1,898,000Source | — | -1,548,000Source | 2,008,000Source | -3,304,000Source |
| General and Administrative ExpenseUSD | — | — | 7,070,000Source | 7,028,000Source | 6,707,000Source | 7,480,000Source | 6,536,000Source | 9,335,000Source | 32,507,000Source | 33,002,000Source | 29,710,000Source | 33,353,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -56,511,000Source | — | — | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 5,241,000Source | 6,068,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -27,182,000Source | -19,506,000Source | -9,553,000Source | -15,938,000Source | -3,400,000Source | -19,608,000Source | -61,477,000Source | -85,192,000Source | -64,373,000Source | -105,032,000Source |
| Operating Costs and ExpensesUSD | — | — | 14,520,000Source | 15,158,000Source | 12,412,000Source | 14,910,000Source | 11,394,000Source | 17,686,000Source | 61,292,000Source | 67,890,000Source | 57,440,000Source | 68,864,000Source |
| Research and Development ExpenseUSD | — | — | 7,450,000Source | 8,130,000Source | 5,705,000Source | 7,430,000Source | 4,858,000Source | 8,351,000Source | 28,785,000Source | 34,888,000Source | 27,730,000Source | 35,511,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | 1,932,000Source | 1,683,000Source |
| Amortization of Intangible Assets | — | — | — | — | —Source | — | —Source | — | — | — | — | — |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | —Source | — | — | — | — | — |
Offerings
Registration 333-291044
Filing attachments
nwbo-20251231xex4d1.htm · 10-K · 2026-04-15
Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the common stock of Northwest Biotherapeutics, Inc. (the “Corporation,” “us,” “our” or ”we”) does not purport to be complete and is subject to, and qualified in its entirety by, our certificate of incorporation, as amended (“certificate”), and our amended and restated bylaws (“bylaws”), each of which is incorporated by reference as an exh…
Read attachment ↗